Tempus AI
{{Short description|American health technology company}}
{{Use mdy dates|date=June 2024}}
{{Infobox company
| name = Tempus AI, Inc.
| logo = Tempus AI logo.png
| former_name = Tempus Labs
| type = Public
| traded_as = {{Nasdaq|TEM}}
| industry = Health technology
| founded = {{start date and age|2015}}
| founder = Eric Lefkofsky
| hq_location = 600 West Chicago Avenue, Chicago, Illinois, US
| key_people = Eric Lefkofsky (CEO)
| num_employees = 2,300 (2024)
| website = {{url|tempus.com}}
}}
Tempus AI, Inc. (formerly Tempus Labs{{Cite news |last=Pletz |first=John |date=November 12, 2021 |title=A Tempus IPO will give Lefkofsky a shot at post-Groupon redemption |url=https://www.chicagobusiness.com/technology/tempus-ipo-would-give-lefkofsky-shot-redemption-after-groupon |work=Crain's Chicago Business}}) is an American health technology company{{cite web | url=https://www.cnbc.com/2021/05/25/tempus-disruptor-50.html | title=16. Tempus | website=CNBC | date=May 25, 2021 }} founded in 2015 by Eric Lefkofsky in Chicago, Illinois.{{cite web |last=Rosenbaum |first=Leah |date=December 10, 2020 |title=EXCLUSIVE: Billionaire Eric Lefkofsky's Tempus Raises $200 Million to Bring Personalized Medicine to New Diseases |url=https://www.forbes.com/sites/leahrosenbaum/2020/12/10/exclusive-billionaire-eric-lefkofskys-tempus-raises-200-million-to-bring-personalized-medicine-to-new-diseases/?sh=558567182692 |website=Forbes}} It was established by Lefkofsky soon after his wife was diagnosed with breast cancer.{{Cite web |last=Liu |first=Phoebe |title=Billionaire Groupon Founder Eric Lefkofsky's Health Tech Company Goes Public—His Fourth IPO |url=https://www.forbes.com/sites/phoebeliu/2024/06/14/billionaire-groupon-founder-eric-lefkofskys-health-tech-company-goes-public-his-fourth-ipo/ |access-date=2024-06-20 |website=Forbes |language=en}} Tempus uses data and artificial intelligence (AI) to create precision medicine services, including diagnostics,{{Cite web |last=Or |first=Amy |date=June 14, 2024 |title=Medical Data Firm Tempus AI Rises After $410.7 Million IPO |url=https://www.bloomberg.com/news/articles/2024-06-14/medical-data-firm-tempus-ai-rises-after-410-7-million-ipo?srnd=undefined |access-date= |website=Bloomberg}} for oncology, cardiology, radiology, and depression. The company went public on the Nasdaq on June 14, 2024, under the ticker symbol "TEM."{{cite web |last=de León |first=Riley |date=June 14, 2024 |title=Google-backed Tempus AI closes first day of trading up 9% in Nasdaq stock market debut |url=https://www.cnbc.com/2024/06/14/google-backed-tempus-ai-pops-by-as-much-as-15percent-in-nasdaq-debut.html |website=CNBC}}{{cite web |last=de León |first=Riley |date=June 14, 2024 |title=Google-backed Tempus AI closes first day of trading up 9% in Nasdaq stock market debut |url=https://www.cnbc.com/2024/06/14/google-backed-tempus-ai-pops-by-as-much-as-15percent-in-nasdaq-debut.html#:~:text=Tempus%20AI%20rose%20by%20as,2021%20CNBC%20Disruptor%2050%20lists |website=CNBC}}
Business
Tempus does genome sequencing and precision medicine, including diagnostics, primarily for cancer patients, as well as for cardiology patients, radiology, and pharmacogenomic testing for patients with depression.{{cite web |title=AI-enabled precision medicine |url=https://www.tempus.com/?srsltid=AfmBOoru6z1HdXsvcW89WU3kJbh_LtC45Qgfx_fV3bEs08IOt09QRvBZ |website=tempus.com |publisher=Tempus |access-date=30 January 2025}} Tempus has a global presence for its products and services in 34 countries.{{cite web |title=Global presence of our products and services |url=https://www.tempus.com/contact-us/?srsltid=AfmBOorFDvEvv2wS_FFb6U9Wr2zo-8e_LtHM4stzSuOJIqGv_Pcl8ci5 |website=tempus.com |publisher=Tempus |access-date=30 January 2025}} It is headquartered in Chicago, and has offices in New York City, the San Francisco Bay Area, Boston, Washington, D.C., Seattle, Milwaukee, Lewisburg, PA, Calgary, and Barcelona, plus three CAP/CLIA labs in Chicago, the Atlanta area (Peachtree Corners), and Research Triangle Park.{{Cite news |last=Eans |first=Zachary |date=August 4, 2021 |title=Chicago-based precision medicine company plans 200-job expansion into RTP |url=https://www.newsobserver.com/news/business/article253261478.html |work=The News & Observer}}{{cite web |title=Our Locations |url=https://www.tempus.com/contact-us/?srsltid=AfmBOorFDvEvv2wS_FFb6U9Wr2zo-8e_LtHM4stzSuOJIqGv_Pcl8ci5 |website=tempus.com |publisher=Tempus |access-date=30 January 2025}}
Tempus investors include SoftBank Group, Baillie Gifford, New Enterprise Associates, Novo Holdings, Franklin Templeton Investments, T. Rowe Price, Revolution LLC, Google LLC, and others.{{Cite web |date=June 5, 2024 |title=SoftBank-backed Tempus AI seeks up to $6.1 bln valuation in US IPO |url=https://www.reuters.com/markets/deals/tempus-ai-seeks-up-61-bln-valuation-us-ipo-2024-06-05/ |website=Reuters}}
In June 2024, Tempus and SoftBank formed an AI healthcare joint venture in Japan called SB Tempus with a plan to develop personalized treatment recommendations by analyzing medical data with AI.{{Cite news |last=Bridge |first=Anton |date=June 27, 2024 |title=SoftBank Group launches AI healthcare joint venture with Tempus AI |url=https://www.reuters.com/business/healthcare-pharmaceuticals/softbank-group-launches-ai-healthcare-joint-venture-with-tempus-ai-2024-06-27/ |publisher=Reuters}}{{Cite web |last=Park |first=Kate |date=June 27, 2024 |title=SoftBank forms AI healthcare JV in Japan with Tempus |url=https://techcrunch.com/2024/06/27/softbank-forms-ai-healthcare-jv-in-japan-with-tempus/ |website=TechCrunch}} In November that year, Tempus agreed to acquire California-based genetic testing company Ambry Genetics for $600 million in a cash-and-stock deal.{{Cite news |last=Asplund |first=Jon |date=November 4, 2024 |title=Tempus buying genetics lab company for $600 million |url=https://www.chicagobusiness.com/health-care/tempus-ai-buying-ambry-genetics-600m |work=Crain's Chicago Business}}
The company's advisory board includes Jennifer Doudna and Scott Gottlieb. As of 2024, Tempus employs around 2,300 people.{{Cite web |last=Liu |first=Phoebe |date=October 17, 2024 |title=The Billionaire Behind Groupon Is Making A Fortune In An Industry He Swore He'd Never Enter |url=https://www.forbes.com/sites/phoebeliu/2024/10/17/the-billionaire-behind-groupon-is-making-a-fortune-in-an-industry-he-swore-hed-never-enter/ |work=Forbes}}
References
{{reflist}}
Category:2015 establishments in Illinois
Category:2024 initial public offerings
Category:American companies established in 2016
Category:Companies based in Chicago
Category:Companies listed on the Nasdaq
Category:Technology companies of the United States